A 10-Year Cost-Effectiveness Analysis of Metabolic and Bariatric Surgery in Adolescents - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

A Decade-Long Economic Evaluation of Metabolic and Bariatric Surgery for Adolescents

  • By

  • John B. Rode

  • Francesca Lim

  • Todd M. Jenkins

  • Justin R. Ryder

  • Thomas H. Inge

  • Chin Hur

  • Teen-LABS Consortium

  • Michael A. Helmrath

  • Anita P. Courcoulas

  • Marc P. Michalsky

  • Stephanie R. Sisley

  • Carroll M. Harmon

  • June 15, 2026

Share

  • 1

    Pediatric obesity prevalence among children aged 2 to 18 years increased significantly from 2008 to 2023, with severe obesity rising by 44.5%.

  • 2

    Metabolic and bariatric surgery (MBS) has shown effective outcomes for adolescents, with average BMI reductions of 20.6% for Roux-en-Y gastric bypass and 19.2% for sleeve gastrectomy.

  • 3

    Remission rates for type 2 diabetes, hypertension, and dyslipidemia in adolescents after MBS range from 50% to 60%, highlighting its potential benefits.

  • 4

    Despite the efficacy of MBS, its adoption is limited due to concerns about upfront costs and the need for long-term cost-effectiveness data.

  • 5

    The study aims to evaluate the 10-year cost-effectiveness of RYGB and sleeve gastrectomy compared to no surgery for adolescents with severe obesity.

Original Source(s)

A 10-Year Cost-Effectiveness Analysis of Metabolic and Bariatric Surgery in Adolescents

  • by John B. Rode, Francesca Lim, Todd M. Jenkins, Justin R. Ryder, Thomas H. Inge, Chin Hur, Teen-LABS Consortium, Michael A. Helmrath, Anita P. Courcoulas, Marc P. Michalsky, Stephanie R. Sisley, Carroll M. Harmon

  • June 15, 2026

Related Content

FDA approves new treatment for FOP

Total new heterotopic ossification volume decreased with treatment and increased with placebo at week 24.

Evidence and Future Directions for Pediatric Health Care Chatbots: Systematic Review

First MCT8 deficiency therapy approved

Clinical studies showed reductions in circulating thyroid hormone levels and changes in heart rate and systolic blood pressure.